Ximelagatran compared with warfarin for prevention pf thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives,and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V)

Julkaisu

Reference

Halperin JL, and the Executive Steering Comittee, on BEHALF of the Sportif Iii And V Study Investigators. Ximelagatran compared with warfarin for prevention pf thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives,and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). Am Heart J 2003:146:431-438.

Julkaisutiedot

Julkaisutyyppi: Alkuperäisartikkeli.
Kansainvälinen.
Kieli: Englanti.

Publication data

Publication type: Original scientific article.
International.
In English.

Tekijät

Contributors

Kuopion yliopisto

Sisätautien yksikkö
- Matti Halinen

University of Kuopio

Department of Internal Medicine
- Matti Halinen

Kuopion yliopistollinen sairaala

Päivystysalue
- Matti Halinen

Kuopio University Hospital

Department of Accidents and Emergency
- Matti Halinen

Julkaisutietokanta 15.4.2008

Publications Data Base 15.4.2008